abanoquil has been researched along with Coronary Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Flores, NA; Sheridan, DJ | 1 |
| Silke, B; Taylor, SH; Tham, TC; Verma, SP; Zezulka, AV | 1 |
2 other study(ies) available for abanoquil and Coronary Disease
| Article | Year |
|---|---|
Electrophysiological effects of alpha-adrenoceptor stimulation in perfused and superfused myocardium.
Topics: Action Potentials; Adrenergic alpha-Antagonists; Aminoquinolines; Animals; Coronary Disease; Guinea Pigs; Male; Methoxamine; Myocardial Reperfusion; Pressure; Receptors, Adrenergic, alpha; Temperature; Tetrahydroisoquinolines | 1991 |
Haemodynamic dose-response effects of UK-52,046 in ischaemic disease with or without impaired left ventricular function.
Topics: Adrenergic alpha-Antagonists; Adult; Aged; Aminoquinolines; Angina Pectoris; Blood Pressure; Coronary Disease; Dose-Response Relationship, Drug; Exercise; Heart Failure; Heart Rate; Heart Ventricles; Hemodynamics; Humans; Male; Middle Aged; Pulmonary Circulation; Tetrahydroisoquinolines | 1990 |